Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

otherindustries-implications-of-loper-bright-and-relentless

Join Goodwin's leaders in Supreme Court, IP Litigation, and Healthcare practices for a discussion on the implications of recent Supreme Court decisions in the life sciences sector.

Chevron Overturned: Implications of Loper Bright and Relentless for Life Sciences

Summary

Speakers

Brian Burgess

Emily L. Rapalino

Matt Wetzel

David J. Zimmer

Related Content

UK Employment: A Sea Change Ahead

Delaware Chancery Court Grants Software Company’s Motion to Dismiss Stockholder Class Action Lawsuit After Stockholder Vote Cleansed Alleged Improprieties in Connection with Merger

ERISA Litigation Update

Florida District Court Concludes FCA’s Qui Tam Provision Is Unconstitutional

The General Court of the European Union Annuls a €1.5 Billion Fine Against Google AdSense

UK National Security and Investment Regime: Government Publishes Latest Annual Report

Life Sciences Licensing and M&A Update: Catching Up on Recent Decisions Affecting Commercially Reasonable Efforts Definitions and Post-Patent Expiration Royalty Obligations

FTC Finalizes Long-Awaited Rule on Use of Consumer Reviews and Testimonials

Goodwin UK Highly Ranked in Chambers UK 2025

Goodwin Names Carl Metzger as Litigation Department Chair

Benchmark Litigation US 2025 Recognizes 45 Goodwin Litigators

Goodwin Names 35 New Partners

Navigating DOJ Enforcement in Healthcare & Private Equity

Goodwin Named Venture Capital Firm of the Year, Hatch-Waxman Litigation Firm of the Year and Life Cycle Firm of the Year at the 2024 LMG Life Sciences Americas Awards

Navigating the NDCA'S New Whistleblower Protections in the Context of Trade Secret Misappropriation Claims (Daily Journal)

MultiPlan Defense Amid Price-Fixing Scrutiny Gets Boost in Court (Bloomberg Law)

Healthcare

Complex Litigation & Dispute Resolution

Intellectual Property Litigation

Patent Litigation

Appellate and Supreme Court Litigation